ERYTECH Announces Enrollment of First Patients in Phase 3 Clinical Trial Evaluating Eryaspase for the Treatment of Second Line Pancreatic Cancer
September 20, 2018 01:30 ET
|
Erytech Pharma S.A.
LYON, France and CAMBRIDGE, Mass., Sept. 20, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies...
SAGD Announces Presentation Regarding Pharmaceutical CBD to The Utah Hormone Group
September 18, 2018 11:20 ET
|
South American Gold Corp
Las Vegas, NV, Sept. 18, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - Sativa Growth International OTC:SAGD, formerly named South American Gold Corp., announces the presentation and publication...
CrownBio Licenses Translational Breast Cancer Models of Resistance and Metastasis
September 18, 2018 08:00 ET
|
Crown Bioscience
SAN DIEGO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation,...
MediXall.com Announces Expansion into Prescription Discounts with Upcoming Launch of MediXallRx
September 13, 2018 12:44 ET
|
MediXall Group, Inc.
Fort Lauderdale, FL, Sept. 13, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- MediXall Group Inc., (OTCQB: MDXL), creator of MediXall.com, a new generation healthcare marketplace platform designed to...
Cannabis Science Launches New Corporate Advisory Structure; Appoints Presidents for Its Scientific Advisory and International Government Affairs Advisory Boards
September 12, 2018 08:13 ET
|
Cannabis Science, Inc.
IRVINE, CA, Sept. 12, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to...
ERYTECH publie ses résultats financiers et fait le point sur ses activités du premier semestre 2018
September 10, 2018 16:30 ET
|
Erytech Pharma S.A.
Conférence téléphonique et webcast : mardi 11 septembre à 14h30 Confirmation du virage stratégique entrepris vers le développement d’eryaspase dans les tumeurs solidesLancement de l’étude de Phase...
ERYTECH Reports First Half of 2018 Financial Results and Provides Business Update
September 10, 2018 16:30 ET
|
Erytech Pharma S.A.
Conference call and webcast scheduled for Tuesday, September 11that 2:30 pm CET/8:30 am EDT Strategic shift to development of eryaspase for solid tumors confirmedPhase 3 trial for eryaspase in second...
American Associated Pharmacies Taps FDS to Bring its Members a State-of-the-Art Business Intelligence Solution
September 10, 2018 09:48 ET
|
FDS, Inc.
Fort Worth, TX, Sept. 10, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- FDS, Inc. announced today that it has created a strategic partnership with American Associated Pharmacies (AAP) to bring AAP...
BioNebicine Corp. Commences Tests of Nebulizer Device
September 04, 2018 13:48 ET
|
BioNebicine Corp.
St. Petersburg, FL, Sept. 04, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioNebicine Corp. (“BioNebicine” or the “Company”) a privately held biotech company, is pleased to announce that it has...
InCrowd Named as Finalist for Vendor of the Year from PM360
August 21, 2018 09:50 ET
|
InCrowd, Inc
WATERTOWN, Mass., Aug. 21, 2018 (GLOBE NEWSWIRE) -- InCrowd, pioneer of the real-time market intelligence platform for global life sciences, was named a finalist for the Vendor of the Year in the...